文献速递运动医学关节外科

关节镜下从髌下脂肪垫获取脂肪来源间充质干细胞

Arthroscopic Harvest of Adipose-Derived Mesenchymal Stem Cells From the Infrapatellar Fat Pad.
PubMed 文献 · Am J Sports Med · 2017-08-17

本研究为描述性实验室研究,在7例接受前交叉韧带重建的患者中,通过关节镜获取髌下脂肪垫后缘及周围滑膜组织,经AquaVage脂肪采集罐收集、注射器乳化与AdiPrep装置浓缩后,用0.3% I型胶原酶消化分离基质血管组分(SVF)。SVF细胞平均产量为4.86 ± 2.64 × 10^5个/g组织,平均活力为69.03% ± 10.75%;培养扩增的脂肪来源间充质干细胞(ADSCs)占SVF细胞的平均5.85% ± 5.89%,平均产量为0.33 ± 0.42 × 10^5个/g组织。作者结论为:通过关节镜技术可成功获取具有定义间充质干细胞表面标志物的ADSCs。

要点

  • 关节镜下获取的髌下脂肪垫及周围滑膜组织可成功分离出SVF细胞,平均产量4.86 ± 2.64 × 10^5个/g组织,平均活力69.03% ± 10.75%。
  • 培养扩增的ADSCs占SVF细胞的平均5.85% ± 5.89%,平均产量0.33 ± 0.42 × 10^5个/g组织。
  • 与新鲜获取的SVF细胞相比,传代2代的ADSCs表面标志物CD73(96.97% ± 1.72%,P < .01)、CD10(84.47% ± 15.46%,P < .05)和CD166(11.63% ± 7.84%,P < .005)表达显著增加。

核心结论

  • 使用关节镜技术可成功从髌下脂肪垫及相邻滑膜组织获取SVF细胞,并产生符合定义间充质干细胞表面标志物标准的ADSCs。

研究设计与样本

  • 描述性实验室研究,从接受前交叉韧带重建的患者中关节镜下获取髌下脂肪垫后缘及周围滑膜组织,共7例,年龄17至52岁(平均35.14 ± 13.70岁)。

主要发现

  • SVF细胞平均产量为4.86 ± 2.64 × 10^5个/g组织,平均活力为69.03% ± 10.75%。
  • 培养扩增的ADSCs占SVF细胞的平均5.85% ± 5.89%,平均产量为0.33 ± 0.42 × 10^5个/g组织。
  • 非造血细胞(CD45-)中表面抗原百分比为:CD44+(52.21% ± 4.50%)、CD73+CD90+CD105+(19.20% ± 17.04%)、CD44+CD73+CD90+CD105+(15.32% ± 15.23%)。
  • 与新鲜获取的SVF细胞相比,传代2代的ADSCs表面标志物CD73(96.97% ± 1.72%;P < .01)、CD10(84.47% ± 15.46%;P < .05)、CD166(11.63% ± 7.84%;P < .005)表达显著增加。
  • SVF细胞克隆形成效率:第1层平均3.21% ± 1.52%,第2层平均1.51% ± 0.55%;组织特异性染色和定量聚合酶链反应证实向软骨、脂肪和骨组织分化。

临床怎么用

  • 作者结论指出,使用简单的关节镜技术即可获取自体干细胞来源,将使骨科医生更容易获得用于再生手术的祖细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The successful isolation of adipose-derived mesenchymal stem cells (ADSCs) from the arthroscopically harvested infrapatellar fat pad (IFP) would provide orthopaedic surgeons with an autologous solution for regenerative procedures. PURPOSE: To demonstrate the quantity and viability of the mesenchymal stem cell population arthroscopically harvested from the IFP as well as the surrounding synovium. STUDY DESIGN: Descriptive laboratory study. METHODS: The posterior border of the IFP, including the surrounding synovial tissue, was harvested arthroscopically from patients undergoing anterior cruciate ligament reconstruction. Tissue was then collected in an AquaVage adipose canister, followed by fat fractionization using syringe emulsification and concentration with an AdiPrep device. In the laboratory, the layers of tissue were separated and then digested with 0.3% type I collagenase. The pelleted stromal vascular fraction (SVF) cells were then immediately analyzed for viability, mesenchymal cell surface markers by fluorescence-activated cell sorting, and clonogenic capacity. After culture expansion, the metabolic activity of the ADSCs was assessed by an AlamarBlue assay, and the multilineage differentiation capability was tested. The transition of surface antigens from the SVF toward expanded ADSCs at passage 2 was further evaluated. RESULTS: SVF cells were successfully harvested with a mean yield of 4.86 ± 2.64 × 105 cells/g of tissue and a mean viability of 69.03% ± 10.75%, with ages ranging from 17 to 52 years (mean, 35.14 ± 13.70 years; n = 7). The cultured ADSCs composed a mean 5.85% ± 5.89% of SVF cells with a mean yield of 0.33 ± 0.42 × 105 cells/g of tissue. The nonhematopoietic cells (CD45-) displayed the following surface antigens as a percentage of the viable population: CD44+ (52.21% ± 4.50%), CD73+CD90+CD105+ (19.20% ± 17.04%), and CD44+CD73+CD90+CD105+ (15.32% ± 15.23%). There was also a significant increase in the expression of ADSC markers CD73 (96.97% ± 1.72%; P < .01), CD10 (84.47% ± 15.46%; P < .05), and CD166 (11.63% ± 7.84%; P < .005) starting at passage 2 compared with freshly harvested SVF cells. The clonogenic efficiency of SVF cells was determined at a mean 3.21% ± 1.52% for layer 1 and 1.51% ± 0.55% for layer 2. Differentiation into cartilage, fat, and bone tissue was demonstrated by tissue-specific staining and quantitative polymerase chain reaction. CONCLUSION: SVF cells from the IFP and adjacent synovial tissue were successfully harvested using an arthroscopic technique and produced ADSCs with surface markers that meet criteria for defined mesenchymal stem cells. CLINICAL RELEVANCE: An autologous source of stem cells can now be harvested using a simple arthroscopic technique that will allow orthopaedic surgeons easier access to progenitor cells for regenerative procedures.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Dragoo JL, Chang W. Arthroscopic Harvest of Adipose-Derived Mesenchymal Stem Cells From the Infrapatellar Fat Pad. Am J Sports Med. 2017. PMID: 28816507. doi:10.1177/0363546517719454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。